Life Technologies Corp (LIFE.OQ)

LIFE.OQ on NASDAQ Stock Exchange Global Select Market

74.78USD
4:00pm EDT
Price Change (% chg)

$0.18 (+0.24%)
Prev Close
$74.60
Open
$74.65
Day's High
$74.85
Day's Low
$74.65
Volume
346,209
Avg. Vol
519,709
52-wk High
$74.85
52-wk Low
$43.22

LIFE.OQ

Chart for LIFE.OQ

About

Life Technologies Corporation (Life Technologies) is a global life sciences company. The Company's systems, consumables and services enable scientific researchers and commercial markets to accelerate scientific exploration, to discoveries and developments that improve the quality of life. The Company's products are also used in... (more)

Overall

Beta: 0.94
Market Cap (Mil.): $12,836.96
Shares Outstanding (Mil.): 172.08
Dividend: --
Yield (%): --

Financials

  LIFE.OQ Industry Sector
P/E (TTM): 31.52 47.13 37.76
EPS (TTM): 2.37 -- --
ROI: 5.60 -2.58 18.76
ROE: 8.93 -2.66 19.59
Search Stocks

Thermo Fisher profit edges past Street view; shares up

- Thermo Fisher Scientific Inc reported a second-quarter profit that slightly beat Wall Street expectations, and said it was making progress in planning for its $13.6 billion acquisition of genetic testing company Life Technologies Inc .

24 Jul 2013

Roche, Sigma teamed up for failed Life Technologies bid: sources

NEW YORK - Roche Holding AG teamed up with Sigma-Aldrich Corp to make an unsuccessful bid for Life Technologies Corp earlier this year, people familiar with the matter said.

21 May 2013

Roche, Sigma teamed up for failed Life Technologies bid -sources

NEW YORK, May 21 - Roche Holding AG teamed up with Sigma-Aldrich Corp to make an unsuccessful bid for Life Technologies Corp earlier this year, people familiar with the matter said.

21 May 2013

Thermo Fisher profit tops Street view as Life awaits

- Laboratory equipment maker Thermo Fisher Scientific Inc, which this month agreed to acquire Life Technologies Inc for more than $13 billion, on Wednesday reported a higher-than-expected first-quarter profit, helped by a 10 percent rise in specialty diagnostics sales.

24 Apr 2013

Big U.S. corporate takeovers drive 'Merger Monday'

* Barclays No. 3 global M&A adviser, JPMorgan tops league table

15 Apr 2013

Fitch Places Life Technologies' Ratings on Negative Watch

(The following statement was released by the rating agency) NEW YORK, April 15 (Fitch) Fitch Ratings has removed the ratings of Life Technologies Corp (Life Tech), including the 'BBB' Issuer Default Rating (IDR), from Rating Watch Evolving and placed them on Rating Watch Negative. The action follows Thermo Fisher Scientific Inc.'s (Thermo Fisher) announcement that it plans to acquire Life Tech. The ratings apply to approximately $2.2 billion of debt outstanding at Dec. 31, 2012. Key Rating

15 Apr 2013

Thermo Fisher to buy Life Tech for $13.6 billion

NEW YORK - Thermo Fisher Scientific Inc on Monday agreed to buy Life Technologies Corp for $13.6 billion in a deal that would make it one of the top two companies in the hot field of genetic testing.

15 Apr 2013

UPDATE 4-Thermo Fisher to buy Life Tech for $13.6 billion

* Thermo Fisher to pay $76 per share, a 12 percent premium

15 Apr 2013

Fitch Places Thermo Fisher's Ratings on Negative Watch

(The following statement was released by the rating agency) NEW YORK, April 15 (Fitch) Fitch Ratings has placed Thermo Fisher Scientific Inc.'s (Thermo Fisher) ratings, including the 'BBB+' Issuer Default Rating (IDR), on Rating Watch Negative. The action follows the company's announcement that it will acquire Life Technologies Corp. (Life Tech) for a total consideration of about $15.8 billion. The ratings apply to $7.1 billion of debt outstanding at Dec. 31, 2012. A full list of ratings fo

15 Apr 2013

BRIEF-Thermo Fisher Scientific shares up after buyout of Life Tech

NEW YORK, April 15 - Thermo Fisher Scientific Inc : * Shares up 1.3 percent in premarket trade after buyout of Life Tech

15 Apr 2013

Competitors

  Price Change
Johnson & Johnson (JNJ.N) $93.77 +0.27
Novartis AG (NOVN.VX) CHF66.60 +0.35
Merck & Co., Inc. (MRK.N) $48.58 +0.41
Roche Holding Ltd. (ROG.VX) CHF228.00 -3.50
Sanofi SA (SASY.PA) €76.85 -3.32
Onyx Pharmaceuticals, Inc. (ONXX.OQ) $134.40 +3.10
Affymetrix, Inc. (AFFX.OQ) $4.32 +0.52

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks